CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to AZN

FOLFIRI (Fluorouracil (5-FU), leucovorin, irinotecan)

Phase 2
AstraZeneca PLC (AZN)

Phase 2

Development Phase

1

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
Q2 '27
AZNPhase 2

FOLFIRI (Fluorouracil (5-FU), leucovorin, irinotecan) Phase 2 Est. Readout

FOLFIRI (Fluorouracil (5-FU), leucovorin, irinotecan)
Q2 2027~QSTALE
CT.gov
00%
Competitive Landscape
Drug Information

Target Indication

Metastatic Colorectal Cancer

Clinical Trial

NCT06792695

Last updated: 2/9/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.